Skip to main content

Diffuse Large B-Cell Lymphoma

Featured Article
In a new review article published online in Blood Cancer Journal, experts from the Lymphoma Research Foundation, Mayo Clinic Foundation, and Memorial Sloan-Kettering Cancer Center provide an in-depth…
According to study findings published online in Cancer Chemotherapy and Pharmacology, researchers identified the optimal dose of selinexor in patients with diffuse large B-cell.

Interactive Features

True or False: Skipping radiation and receiving less chemotherapy may become the new standard of care.
Back to Top